TREOSUL is now Swissmedic approved and available!!!

  • Home
  • Products & Inquiries
    • Products in Switzerland
    • Morbus Wilson
    • NAFLD
    • Hand-Foot-Syndrome
    • Immunotherapy & Skin
  • Global Site
  • Mehr
    • Home
    • Products & Inquiries
      • Products in Switzerland
      • Morbus Wilson
      • NAFLD
      • Hand-Foot-Syndrome
      • Immunotherapy & Skin
    • Global Site

  • Home
  • Products & Inquiries
    • Products in Switzerland
    • Morbus Wilson
    • NAFLD
    • Hand-Foot-Syndrome
    • Immunotherapy & Skin
  • Global Site

Morbus Wilson Disease

Wilsons Disease

Wilson's disease is an inherited disorder of the copper metabolism and leads to a harmful accumulation of copper in many organs over time. The liver, the nervous system and the brain are particularly affected.

Wilson's disease was first described in 1912 by Samuel Alexander Kinnier Wilson as a rare familial chronic disease of the liver and central nervous system (hepato-lenticular degeneration).

Men and women are equally affected by the disease. According to current knowledge, the prevalence rate of Wilson's disease is 30 per million, which means that one person in 33'333 has the disease.

Cause & Effect

Usually, copper is excreted via the bile ducts into the intestine. In Wilson's disease this metabolism is disturbed by a genetic, autosomal recessive defect.

The blood in the liver stores the copper and from there it reaches the kidneys, the brain and the cornea of the eye. Over the years, a reduced excretion leads to a harmful accumulation of copper in many organs.

In a heterozygous state, the genetic information of a gene is sufficient to ensure a healthy metabolic function. If two defective genes meet, a functional failure occurs. If both parents are carriers of the same defective genetic make-up without becoming ill themselves - it means that they are autosomal recessive. If both parents now inherit the defective gene, the child will develop Wilson's disease.

Symptoms & Diagnosis

There are several symptoms that can indicate Wilson's disease. These often occur between the ages of 5 and 45 with a peak in frequency between the ages of 13 and 24.3

Unclear hepatic, neurological or psychiatric dysfunction, especially in young patients, may indicate Wilson's disease. In children, damage to the liver is often the primary concern. Hepatitis or cirrhosis of the liver may occur.

In adolescents and young adults, neurological deficits come to the fore. There is a disorder of speech motor skills as well as writing disorders, trembling of limbs, gait and swallowing disorders, sometimes also psychological changes.


An early diagnosis is important in order to achieve a lasting improvement of symptoms.

The diagnosis of Wilson's disease is easy once the disease is suspected.

The most important examinations for the diagnosis of Wilson's disease are:

- Laboratory chemical tests: Copper and ceruloplasmin in serum, copper in 24-hour urine

- Liver biopsy with determination of hepatic copper

- Ophthalmological examination after the Kayser-Fleischer corneal ring

- Genetic test

Treatment

Permanent medicinal treatment with copper chelators (D-penicillamine, Trientine) or zinc salts is necessary. With lifelong consistent treatment and consistent therapy, the prognosis is favourable.

The aim of the treatment is to reduce the copper content in the body by removing the excess copper through medication. These include chelating agents (Trientine and D-penicillamine) and zinc. Those affected must continue this treatment throughout their lives, e.g. even during pregnancy. Avoiding foods with a high copper content is a sensible accompanying measure.


A control of the copper metabolism every six months is essential. In addition, regular liver monitoring (liver values and ultrasound) is necessary and the examination of neurological symptoms is recommended.

If acute inflammation of the liver with liver failure occurs during the course of the disease, a liver transplant may be necessary; the new liver can excrete copper in the normal way.


Careful family screening is advisable, as even patients who have not yet developed symptoms must be treated adequately at an early stage. This is the only way to protect patients without symptoms from disease progression and possible complications.

General note:

This information is for general information purposes only. It should not be used for the diagnosis or treatment of a disease and does not replace consultation with a doctor.

For more information contact: morbuswilson@ideogen.com


See also MORBUS WILSON ASSOCIATION:  

https://www.morbus-wilson.ch/ 


Copyright © 2018 Ideogen  – reserved all rights


 

COPYRIGHT 

  • All the information on our website has been carefully checked and its contents are continually being added to and updated. Nonetheless, although we carefully check the content, we cannot guarantee that it is complete, correct or fully up to date. 


COPYRIGHT & TRADEMARKS 

  • The royalty-free use, copying or distribution of this documentation is hereby granted only for non-commercial purposes, provided the copyright notice set out here appears in all copies and both the copyright and this notice of permission appear in supporting documents. Use of the name Ideogen in advertising in connection with the distribution of this documentation requires the specific written permission of Idoegen. All information, documents, and images on this page are the property of the Ideogen and may only be used on this page. Use without prior consent is prohibited. 


HEALTH INFORMATION 

  • This website may contain medical and health-related information. This information cannot, however, be considered to be substitute for the advice of a doctor, pharmacist or other health professional, and should not be used for self-diagnosis or the diagnosis of other persons. Scientific data and information regarding development of products or therapies correspond to the situation when they were first published and are therefore subject to change of any kind. 


DISCLAIMER 

  • We make every effort to provide you with accurate and up-to-date information. However, Ideogen accepts no responsibility for damage associated with this information or changes to it. For this reason, we give neither expressly nor implicitly any warranty or guarantee and do not assure respect for the correctness or completeness of the information provided or referred to. Any use of our website or any other pages linked to it by means of hyperlinks or their content is at the user's risk. Neither Ideogen nor its subsidiaries nor any other party concerned with the manufacture, provision, design or maintenance of the entire internet offering or individual parts thereof are in any way liable for any immediate or consequential damage, culpable damage or damage regardless of culpability which might arise from access to the internet offering, its use or in particular the inability to use the internet offering of Ideogen or the information provided in connection with it. Ideogen is not responsible for the availability of the websites of third parties or their content. Any use of hyperlinks to these websites is at the user's risk and implies no liability on the part of Ideogen. Before using or applying our products, a note should be taken of the related instructions for use. Rights may only be inferred from the instructions included with the products and not from the use of the product information on this website. 

  • Global Site

UNMET NEEDS, MET FASTER

The Morbus Wilson Treatment is now SWISSMEDIC APPPROVED, on the SL list and availabe for your patients!

GET MORE INFORMATION HERE....